Serial Number | 79249526 |
Word Mark | EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS |
Filing Date | Friday, September 28, 2018 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 2, 2019 |
Registration Number | 5791084 |
Registration Date | Tuesday, July 2, 2019 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, April 16, 2019 |
Description of Mark | The mark consists of the wording "EMPRISE" in black font. Below this is the wording "EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS" in blue. To the right of the wording is a red heart with magnifying glass covering the upper right portion of the heart. The magnifying glass is white and the lens of the magnifying glass is purple. Inside the lens is a stylized outline of a globe that transitions from white to purple from right to left. The color white appearing elsewhere in the mark is for background purposes only and is not claimed as a feature of the mark. |
Pseudo Mark | EMPRISE EMPAGLIFLOZIN REAL WORLD EFFECTIVENESS |
Indication of Colors claimed | The color(s) black, white, blue, purple, and red is/are claimed as a feature of the mark. |
NOT AVAILABLE | "EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS" |
Goods and Services | Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 16, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Boehringer Ingelheim International GmbH |
Party Type | 30 - Original Registrant |
Legal Entity Type | 27 - NOT AVAILABLE |
Address | DE |
Party Name | Boehringer Ingelheim International GmbH |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 27 - NOT AVAILABLE |
Address | DE |
Party Name | Boehringer Ingelheim International GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 27 - NOT AVAILABLE |
Address | DE |
Event Date | Event Description |
Tuesday, January 22, 2019 | APPLICATION FILING RECEIPT MAILED |
Thursday, January 10, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Wednesday, January 16, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, January 16, 2019 | ASSIGNED TO EXAMINER |
Wednesday, January 23, 2019 | NON-FINAL ACTION WRITTEN |
Thursday, January 24, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, February 6, 2019 | REFUSAL PROCESSED BY MPU |
Wednesday, February 6, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, February 22, 2019 | REFUSAL PROCESSED BY IB |
Thursday, March 7, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 8, 2019 | EXAMINERS AMENDMENT -WRITTEN |
Friday, March 8, 2019 | EXAMINER'S AMENDMENT ENTERED |
Friday, March 8, 2019 | EXAMINERS AMENDMENT MAILED |
Wednesday, March 27, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 16, 2019 | PUBLISHED FOR OPPOSITION |
Tuesday, April 16, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Thursday, March 7, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 7, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Saturday, March 9, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, April 19, 2019 | CORRECTION TRANSACTION RECEIVED FROM IB |
Tuesday, July 2, 2019 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, October 2, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Wednesday, October 23, 2019 | GENERIC MADRID TRANSACTION CREATED |
Wednesday, October 23, 2019 | GENERIC MADRID TRANSACTION SENT TO IB |
Tuesday, July 2, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Sunday, December 1, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Monday, May 6, 2019 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |